About – Immunespec

Driven by Expertise: The Team Behind ImmuneSpecs’ Innovative Mission

Immunopeptidomics or MHC associated peptide proteomics (MAPPs) enables the highly sensitive identification of peptides presented by MHC molecules, allowing for an unprecedented understanding of antigen presentation. This technology now makes it possible to precisely map T cell epitopes in biotherapeutics and to identify and validate targets for immunotherapy with unmatched accuracy.

Our team represents 20+ years of expertise in peptidomics. The deep scientific expertise enables customers to make unparalleled data-driven decisions regarding their questions.

“We provide the expertise and agility to accelerate your success.”

OUR VISION

Your Trusted Partner for Precision Immunopeptidomics Solutions

We envision a future where we can fully decode the immune system, enabling the development of biotherapeutics free from unwanted immunogenicity, driving vaccine innovation, and unlocking each patient’s immune system to its full potential to find a cure for every cancer.

More about our technology

OUR MISSION

Transforming Biotherapeutic Development with Cutting-Edge Immunopeptidomics Services

Our mission is to deliver the highest-quality immunopeptidomics analysis as a service, making this advanced technology accessible to all biotech and pharma companies.

Let’s get in touch

MEET

Our team

The true value of ImmuneSpec lies in the exceptional team behind it. With rigorous scientific expertise, technical excellence, and an unwavering commitment to quality, we work together to ensure that every step—from sample preparation to data analysis and interpretation—meets the highest standards. Our collaborative and detail-driven approach allows us to push the boundaries of immunopeptidomics, delivering precise, high-sensitivity analyses that empower our customers with data-driven insights into the MHC presented peptides that truly matter.